Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2012
Headcount
5
HQ
Ramat Gan, Israel
Sector
Health Tech & Life Sciences
About
GlucoCheck is developing a proprietary, patent-pending solution for self-monitoring of blood glucose (SMBG). GlucoCheck offers pain-free, alternative-site SMBG designed to meet FDA and medical staff requirements as a permanent replacement for fingertip SMBG.
Q&A
- What is GlucoCheck's primary focus?
- GlucoCheck is developing a proprietary, patent-pending solution for pain-free self-monitoring of blood glucose (SMBG), aiming to replace traditional fingertip SMBG.
- When was GlucoCheck founded?
- GlucoCheck was founded in December 2012.
- What is the current status of GlucoCheck?
- GlucoCheck is currently inactive and ceased to operate in May 2018.
- Where is GlucoCheck headquartered?
- GlucoCheck is headquartered in Ramat Gan, Center District, Israel.
- How many employees did GlucoCheck have?
- GlucoCheck had 5 employees, falling into the 1-10 employee bucket.
- Who is the founder of GlucoCheck?
- Adi Kahn is the founder of GlucoCheck.
- In which sector does GlucoCheck operate?
- GlucoCheck operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Monitors.
- What is GlucoCheck's product stage?
- GlucoCheck's product was in the R&D stage.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Monitors
Target customers
Healthcare & Life SciencesHealthcarePatientsConsumers
Business model
B2C
Highlights
Verified
Tags
real-timepain-freediabetesmedical-devicesmonitoringpatientshome-careadherence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2012-12 |
|---|---|
| Employees (exact) | 5 |
| Status reason | Non Active, May 2018 ceased to operate |